DIGEMID — Discontinuidad de Medicamentos (Peru) (DIGEMID)

DIGEMID — Discontinuidad de Medicamentos (Peru) is the official source of medicine shortage information for Peru (Latin America). Mederti checks its register regularly and links every notice back to the original publication.

Official register

serviciosweb-digemid.minsa.gob.pe

Country

Peru

Notices tracked by Mederti

1,735

Last checked

1 Nov 2026

Latest notices from DIGEMID

• Mesilato De Bromocriptina — anticipated, medium, since 30 Jun 2027 (source)
• Macitentan; Tadalafil — anticipated, medium, since 11 Apr 2027 (source)
• Clotrimazolo — anticipated, medium, since 31 Mar 2027 (source)
• Clorhidrato De Ambroxol — anticipated, medium, since 5 Mar 2027 (source)
• Sulfato De Bario Rovi Tac — anticipated, medium, since 13 Jan 2027 (source)
• Metronidazolo — anticipated, medium, since 10 Jan 2027 (source)
• Candesartan Cilexetil — anticipated, medium, since 1 Jan 2027 (source)
• Clorhidrato De Ambroxol — anticipated, medium, since 31 Dec 2026 (source)
• Nitrofurantoina — anticipated, medium, since 8 Dec 2026 (source)
• Cloruro Di Calcio + Glicina + Glucosio (Destrosio) Anidro + L-Alanina + L-Arginina + L-Fenilalanina + L-Isoleucina + L-Istidina + L-Leucina + L-Lisina + L-Metionina + L-Prolina + L-Serina + L-Tirosina + L-Treonina + L-Triptofano + L-Valina + Magnesio Solfato + Potassio Cloruro + Sodio Acetato + Sodio Glicerofosfato + Taurina — anticipated, medium, since 1 Dec 2026 (source)
• Citrato De Cafeina — anticipated, medium, since 1 Dec 2026 (source)
• Clortalidona — anticipated, medium, since 1 Dec 2026 (source)
• Telmisartan — anticipated, medium, since 27 Nov 2026 (source)
• Rivaroxaban — anticipated, medium, since 11 Nov 2026 (source)
• Cannabidiol — anticipated, medium, since 11 Nov 2026 (source)

Mederti is not affiliated with or endorsed by DIGEMID — Discontinuidad de Medicamentos (Peru). All notices remain the property of their publisher and are linked to the original source.